Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;18(2):241-251.
doi: 10.1007/s10689-018-0106-2.

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma

Affiliations

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma

Evan J Walker et al. Fam Cancer. 2019 Apr.

Abstract

Hereditary predisposition is estimated to account for 10% of all pancreatic cancer cases. However, referral patterns and clinical workflow for germline testing in this disease differ significantly by institution, and many at-risk patients may not undergo appropriate counseling and testing. We undertook an analysis of patients diagnosed with pancreatic cancer (PDAC) who were referred to the Clinical Genetics program of a high-volume academic center over a 3-year period to assess referral frequency, evaluate the yield of germline testing in this selected patient cohort, and elucidate the reasons individuals did not undergo recommended germline testing. Medical records of patients with PDAC referred for genetic counseling between January 2015 and October 2017 were reviewed for demographic, medical/family history, and disease-specific data. If testing did not occur, reasons were documented. Genetic test results were categorized as negative, variants of unknown significance, or established pathogenic mutations. Descriptive statistics included means with standard deviations; associations were analyzed with t test and Fisher's exact test. 32% (137 of 432) of PDAC patients were referred for genetic counseling, but only 64% attended their appointment and 60% ultimately underwent germline testing. Common reasons for attrition included worsening disease severity, lack of patient follow-up, insurance concerns, and logistic/travel challenges. Pathogenic germline mutations were detected in 20% (16 of 82) of patients tested, distributed across races/ethnicities, and significantly associated with younger age and positive family history of breast cancer. PDAC patients frequently do not undergo genetic counseling/germline testing despite appropriate referrals, highlighting a need to develop streamlined processes to engage more patients in testing, especially those with high-risk features.

Keywords: Genetic counseling; Germline testing; Pancreatic cancer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Ther. 2016 Jul;38(7):1622-35 - PubMed
    1. Cell Cycle. 2011 Jun 1;10(11):1757-63 - PubMed
    1. Gastroenterology. 2001 Dec;121(6):1310-9 - PubMed
    1. Semin Oncol. 2016 Oct;43(5):548-553 - PubMed
    1. Clin Cancer Res. 2018 Mar 15;24(6):1326-1336 - PubMed

MeSH terms

LinkOut - more resources